⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for nintedanib (bibf1120)

Every month we try and update this database with for nintedanib (bibf1120) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLCNCT00806819
Carcinoma, Non-...
Nintedanib (BIB...
Pemetrexed
pemetrexed
B12
dexamethasone (...
placebo
dexamethasone (...
B12
Folic Acid
B12
dexamethasone (...
Folic Acid
placebo
Folic Acid
Nintedanib (BIB...
Pemetrexed
18 Years - Boehringer Ingelheim
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: